The practice of family medicine in Canada was in considerable decline in the years leading up to the founding of The College of Family Physicians of Canada in 1954.
The College of Family Physicians of Canada (CFPC) published preliminary guidelines for the Physicians in Canada.
The regulatory board governing doctors in Canada states that the new Marijuana for Medical Purposes Regulations (MMPR) has put doctors in a "difficult position: we are asked to authorize our patients’ access to a product with little evidence to support its use, and in the absence of regulatory oversight and approval."
According to this regulatory body, physicians in Canada must be on the alert for 'cannabis use disorder' in those patients seeking medical marijuana.
This regulatory board further contends that by grouping cannabis in with cocaine, alcohol and other drugs, a number of harmful effects exist in cannabis, alcohol, cocaine, amphetamines, etc.
The CFPC advises doctors in Canada to consider a trial of pharmaceutical cannabinoids before conceding and agreeing to dried marijuana since, they assert, that no researched evidence exists to support authorizing the use of dried marijuana. This is despite the fact that clinical trials with cannabis actually began in 1974.
The board governing family Physicians in Canada are advised to counsel those patients seeking marijuana that are suspected of a 'cannabis use disorder' to send them to an addiction treatment facility.
With the above information and reference, is it not evident that the pharmaceutical industry controls, and always have controlled those we call our health care professionals?
No comments:
Post a Comment